Skip to content

Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes

Improving the Cost-effectiveness of Therapeutic Shoes for Diabetic Patients With a Previous Foot Ulcer Using an In-shoe Pressure Device

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02061059
Enrollment
40
Registered
2014-02-12
Start date
2014-03-31
Completion date
2015-06-30
Last updated
2014-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Polyneuropathies

Brief summary

The purpose of this study is determine whether the use of plantar pressure measurements in the production of customized therapeutic footwear for patients with diabetes and a history of foot ulceration results in lower production costs and more pressure relief, compared to the standard production. A secondary objective is to explore if a difference in durability can be observed in pressure reduction and development of (pre-) ulcerative lesions between the shoes produced with and without plantar pressure measurements.

Detailed description

For each patient two pairs of shoes will be produced by two shoemakers, one using plantar pressure measurements and one according current standard production procedures. The patient will wear one of these two pairs of shoes during a period of 3 months.

Interventions

OTHERblock 1

shoemaker 1 produces shoes according to standard methods, shoemaker 2 uses plantar pressure measurements

OTHERblock 2

shoemaker 2 produces shoes according to standard methods, shoemaker 1 uses plantar pressure measurements

OTHERstandard

patient wears shoes produced with standard method

OTHERwith measurements

patient wears shoes produced with plantar pressure measurements

Sponsors

Maastricht University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* diabetes * neuropathy * prescription of therapeutic footwear * diabetic foot ulcer in the last 5 years * receiving regular preventive foot care * written informed consent

Exclusion criteria

* peripheral arterial disease * not motivated to wear therapeutic footwear * active foot ulcer * recent vascular intervention * severe mobility impairment * amputation more proximal than toes, except a single ray amputation is allowed. * severe visual impairment * active cancer * severe cardiac/ pulmonary failure * severe oedema * chronic drug abuse * severe psychiatric illness * hospital admission at the time of inclusion * any condition that may interfere with follow-up visits.

Design outcomes

Primary

MeasureTime frame
The cost-effectiveness of shoes produced with and without plantar pressure measurements.approximately 10 weeks (at delivery of the shoes)

Secondary

MeasureTime frameDescription
Change in plantar pressure after wearing the therapeutic shoes for 3 months.approximately 22 weeks (at follow-up)
The number of participants with reported and/ or visible new diabetic foot problems, such as ulcera or pre-ulcerative lesions.approximately 22 weeks (at follow-up)The number of diabetic foot problems serves as an additional measure of the quality of the therapeutic shoes produced.
Differences in production techniques, materials and procedures used by the two shoemakers to produce the two pair of shoes.approximately 10 weeks (at delivery of the shoes)Qualitative measure of differences in production process of the shoes produced with or without plantar pressure measurements.
Differences in plantar pressures between the two shoes produced.approximately 10 weeks (at delivery of the shoes)
The use and usability of the shoes produced, measured with the questionnaire Monitor Orthopaedic Shoes.approximately 22 weeks (at follow-up)

Countries

Netherlands

Contacts

Primary ContactTom Melai, PhD
tom.melai@MaastrichtUniversity.nl+31 43 3881398

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026